133 related articles for article (PubMed ID: 6259)
21. Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats.
Dusková J; Schreiber V
Endocrinol Exp; 1989 Sep; 23(3):185-94. PubMed ID: 2572415
[TBL] [Abstract][Full Text] [Related]
22. Lisuride, a dopamine agonist, inhibits DNA synthesis in the pituitary gland.
Burdman JA; Calabrese MT; Harcus CT; MacLeod RM
Neuroendocrinology; 1982 Oct; 35(4):282-6. PubMed ID: 7145022
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the growth reaction of the rat adenohypophysis to oestrogen by an ergoline derivative.
Schreiber B; Pribýl T; Rohácová J
Physiol Bohemoslov; 1973; 22(1):11-7. PubMed ID: 4269742
[No Abstract] [Full Text] [Related]
24. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
Lloyd HM; Meares JD; Jacobi J
Nature; 1975 Jun; 255(5508):497-8. PubMed ID: 1138203
[No Abstract] [Full Text] [Related]
25. Recent findings on prolactin transformation by the lactating rat pituitary.
Mena F; Montiel JL; Aguayo D; Morales MT; Arámburo C
Endocr Regul; 1993 Sep; 27(3):105-13. PubMed ID: 8193309
[No Abstract] [Full Text] [Related]
26. [Inhibition of lactation in the rat following administration of D-6-methyl-8-ergolin-I-yl-acetic acid-amide tartrate (VUFB-6683)].
Ausková M; Rezábek K; Semonský M
Arzneimittelforschung; 1973 Apr; 23(4):617-8. PubMed ID: 4740246
[No Abstract] [Full Text] [Related]
27. Synthesis of prolactin and RNA in rat adenohypophysis after prolonged administration of estrogens.
De Nicola AF; Kaplan SE
Acta Physiol Lat Am; 1975; 25(3):238-40. PubMed ID: 1232759
[No Abstract] [Full Text] [Related]
28. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G
Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
[No Abstract] [Full Text] [Related]
29. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
Gräf KJ; Horowski R; Etreby MF
Acta Endocrinol (Copenh); 1977 Jun; 85(2):267-78. PubMed ID: 325978
[TBL] [Abstract][Full Text] [Related]
30. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
Floss HG; Cassady JM; Robbers JE
J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
[No Abstract] [Full Text] [Related]
31. Normal and abnormal prolactin metabolism.
Chang RJ
Clin Obstet Gynecol; 1978 Mar; 21(1):125-37. PubMed ID: 24508
[No Abstract] [Full Text] [Related]
32. Effects of estrogen and tamoxifen on the ultrastructural characteristics of female rat prolactin cells as evaluated by immunogold technique.
Erensoy N; Cagatay P; Yilmazer S
Acta Histochem; 2005; 107(3):199-205. PubMed ID: 15993477
[TBL] [Abstract][Full Text] [Related]
33. A solubility shift occurs during depletion-transformation of prolactin within the lactating rat pituitary.
Mena F; Martinez-Escalera G; Clapp C; Aguayo D; Forray C; Grosvenor CE
Endocrinology; 1982 Oct; 111(4):1086-91. PubMed ID: 7117192
[No Abstract] [Full Text] [Related]
34. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
35. Effect of D-6-methyl-8-ergoline-I-ylacetamide (Deprenon) on the FSH content of the rat pituitary during the oestrus cycle and pregnancy.
Chlebounová J; Rezábek K; Seda M; Semonský M
Physiol Bohemoslov; 1974; 23(2):113-8. PubMed ID: 4280585
[No Abstract] [Full Text] [Related]
36. Ergolines as potential prolactin and mammary tumor inhibitors.
Cassady JM; Floss HG
Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
[No Abstract] [Full Text] [Related]
37. Growth hormone and prolactin content of hyperplastic anterior pituitary of dehydroepiandrosterone treated rats.
Halmy L; Nagy I; Kurcz M
Endokrinologie; 1975 Dec; 66(3):241-9. PubMed ID: 129325
[TBL] [Abstract][Full Text] [Related]
38. Stress- as well as suckling-induced prolactin release is blocked by a structural analogue of the putative hypophysiotrophic prolactin-releasing factor, salsolinol.
Bodnár I; Mravec B; Kubovcakova L; Tóth EB; Fülöp F; Fekete MI; Kvetnansky R; Nagy GM
J Neuroendocrinol; 2004 Mar; 16(3):208-13. PubMed ID: 15049851
[TBL] [Abstract][Full Text] [Related]
39. The roles of dopamine and the neurointermediate lobe of the pituitary in the regulation of prolactin secretion during late pregnancy in rats.
Andrews ZB; Grattan DR
J Neuroendocrinol; 2004 Oct; 16(10):859-65. PubMed ID: 15500546
[TBL] [Abstract][Full Text] [Related]
40. Stimulation and inhibition of prolactin release by prolactin-releasing Peptide in rat anterior pituitary cell aggregates.
Swinnen E; Boussemaere M; Denef C
J Neuroendocrinol; 2005 Jun; 17(6):379-86. PubMed ID: 15929743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
